| Dr John A Bowers Jr, MD | |
|
500 E Windmill Ln, Suite 140, Las Vegas, NV 89123-1843 | |
| (702) 240-6482 | |
| (702) 804-0957 |
| Full Name | Dr John A Bowers Jr |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 500 E Windmill Ln, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811919665 | NPI | - | NPPES |
| 002019314 | Medicaid | NV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Rose Dominican Hospitals - Siena Campus | Henderson, NV | Hospital |
| Henderson Hospital | Henderson, NV | Hospital |
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Southern Hills Hospital And Medical Center | Las vegas, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nevada Heart And Vascular Center Resh Llp | 5395746283 | 38 |
News Archive
USA Today reports that the Supreme Court's review could cause the the health law debate to stretch through the presidential campaign. Other media outlets take a look at what would happen without the individual mandate, and at stakeholders' positions related to the law's Medicaid expansion.
In an Intellectual Property Watch column, Daniele Dionisio, of the Italian Network for International Fight against AIDS, examines how trade rules and policy directions by governments and institutions may help to improve countries' access to antiretrovirals.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
A new assistive technology developed by engineers at the Georgia Institute of Technology could help individuals with severe disabilities lead more independent lives.
Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the company's first quarter ended March 31, 2011.
› Verified 7 days ago
| Entity Name | Nevada Heart And Vascular Center Resh Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659387934 PECOS PAC ID: 5395746283 Enrollment ID: O20070119000174 |
News Archive
USA Today reports that the Supreme Court's review could cause the the health law debate to stretch through the presidential campaign. Other media outlets take a look at what would happen without the individual mandate, and at stakeholders' positions related to the law's Medicaid expansion.
In an Intellectual Property Watch column, Daniele Dionisio, of the Italian Network for International Fight against AIDS, examines how trade rules and policy directions by governments and institutions may help to improve countries' access to antiretrovirals.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
A new assistive technology developed by engineers at the Georgia Institute of Technology could help individuals with severe disabilities lead more independent lives.
Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the company's first quarter ended March 31, 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John A Bowers Jr, MD 700 E Silverado Ranch Blvd, Suite 170, Las Vegas, NV 89183-7516 Ph: (702) 240-6482 | Dr John A Bowers Jr, MD 500 E Windmill Ln, Suite 140, Las Vegas, NV 89123-1843 Ph: (702) 240-6482 |
News Archive
USA Today reports that the Supreme Court's review could cause the the health law debate to stretch through the presidential campaign. Other media outlets take a look at what would happen without the individual mandate, and at stakeholders' positions related to the law's Medicaid expansion.
In an Intellectual Property Watch column, Daniele Dionisio, of the Italian Network for International Fight against AIDS, examines how trade rules and policy directions by governments and institutions may help to improve countries' access to antiretrovirals.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
A new assistive technology developed by engineers at the Georgia Institute of Technology could help individuals with severe disabilities lead more independent lives.
Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the company's first quarter ended March 31, 2011.
› Verified 7 days ago
Dr. Arshi A. Quadeer, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |